Crinetics Pharmaceuticals CRNX Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's common stock shares outstanding?
- Crinetics Pharmaceuticals (CRNX) reported common stock shares outstanding of $121.56M in Q1 2026.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.